The carboxy therapy market size has grown rapidly in recent years. It will grow from $12.07 billion in 2025 to $13.4 billion in 2026 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to growth in aesthetic medicine procedures, rising consumer awareness of minimally invasive treatments, increased availability of professional aesthetic devices, expansion of dermatology and cosmetic clinics, growing acceptance of aesthetic therapies.
The carboxy therapy market size is expected to see rapid growth in the next few years. It will grow to $20.57 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for personalized cosmetic treatments, rising adoption of regenerative medicine techniques, expansion of wellness and preventive care services, growing focus on evidence-based aesthetic outcomes, increasing investments in advanced therapy devices. Major trends in the forecast period include increasing adoption of personalized aesthetic treatment protocols, rising integration of combination therapy approaches, expansion of non-invasive skin rejuvenation procedures, increasing focus on collagen stimulation therapies, enhanced demand for clinical outcome monitoring.
The growing prevalence of skin aging and cosmetic concerns is anticipated to drive the growth of the carboxy therapy market in the coming years. Skin aging and cosmetic concerns refer to visible signs such as wrinkles, fine lines, skin laxity, dark circles, cellulite, and uneven skin texture experienced by both aging and younger populations globally. The growing prevalence of skin aging and cosmetic concerns is driven by prolonged exposure to ultraviolet radiation, environmental pollution, and lifestyle-related factors that accelerate collagen breakdown and skin degeneration. Carboxy therapy supports the prevalence of skin aging and cosmetic concerns by improving microcirculation, enhancing oxygen delivery, and stimulating collagen regeneration, thereby addressing multiple aesthetic indications through a minimally invasive approach. For example, in June 2024, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization, facial and head aesthetic procedures experienced significant growth compared to the previous year in 2023, totaling over 6.5 million interventions and reflecting a 19.6% rise. Therefore, the growing prevalence of skin aging and cosmetic concerns is driving the growth of the carboxy therapy market.
Companies operating in the carboxy therapy market are focusing on developing innovative solutions, such as patented sustained carbon dioxide delivery systems for professional‑grade carboxytherapy treatments, to meet the rising demand for safer, more effective non-invasive aesthetic and regenerative skin therapies. Patented sustained carbon dioxide delivery systems are advanced formulations and device technologies that gradually release carbon dioxide over an extended period, enabling deeper skin absorption and enhanced circulation compared with traditional fast-acting gels and packs that dissipate quickly on contact. For example, in August 2025, Lumisque Skincare, a US-based clinical skincare and biomedical company, announced advancements in its CO2Lift carboxytherapy treatment, featuring a patented lactone hydrolysis system that steadily releases carbon dioxide for more than an hour to support deeper tissue absorption and broader therapeutic use. The CO2Lift system is being integrated by physicians and aesthetic practitioners for non-invasive skin regeneration, wound healing support, and enhanced microcirculation, offering a professional‑grade alternative to traditional consumer-grade CO₂ products. Lumisque’s clinical validation and physician adoption underscore the technology’s capability to elevate carboxy therapy beyond basic cosmetic applications, reflecting continued innovation in the market.
In October 2024, PYFAESTHETIC, an Indonesia-based provider of aesthetic dermatology products, medical devices, and professional skincare solutions, collaborated with JM Biotech to bring the latest non-surgical treatment option to Indonesia. With this collaboration, PYFAESTHETIC aimed to expand its dermatology and aesthetic treatment portfolio and accelerate market adoption of non-invasive carboxytherapy through clinical education, product launches, and localized practitioner training. JM Biotech is a South Korea-based provider of CO₂ carboxytherapy products and biotechnology-driven aesthetic solutions.
Major companies operating in the carboxy therapy market are Cynosure Inc., Alma Lasers Ltd., Cosmopro Srl, Cocoon Medical Ltd., MBE Medical Divisions GmbH, Carbossiterapia Italiana Srl, DTA Medical GmbH, Alvi Prague Co., Kastner-Praxisbedarf GmbH, MEDAiON Plasma GmbH, Beijing Jontelaser Technologies Co. Ltd., HyaCorp GmbH, Sublime Skin Ltd., Hyaluronic GmbH, Aesthetic Solutions Ltd., RevitaLaze GmbH, Medcos GmbH, Mezopharma GmbH, Advon Technologies Pvt. Ltd., and Solana Beauty Technology Co. Ltd.
Tariffs are impacting the carboxy therapy market by increasing costs of imported medical-grade carbon dioxide cylinders, delivery devices, precision regulators, and professional treatment equipment. Aesthetic clinics and medical centers in North America and Europe are most affected due to dependence on imported consumables and devices, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising treatment costs and limiting equipment upgrades. However, they are also encouraging local production of consumables, regional device manufacturing, and innovation in cost-efficient delivery systems that support broader clinical adoption.
The carboxy therapy market research report is one of a series of new reports that provides carboxy therapy market statistics, including carboxy therapy industry global market size, regional shares, competitors with a carboxy therapy market share, detailed carboxy therapy market segments, market trends and opportunities, and any further data you may need to thrive in the carboxy therapy industry. This carboxy therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Carboxy therapy is a minimally invasive medical and cosmetic treatment that involves the controlled injection of medical-grade carbon dioxide beneath the skin or into the dermal layers. The procedure enhances blood flow, promotes collagen formation, and improves tissue oxygen levels. It supports better skin texture, firmness, and localized fat metabolism through improved microcirculation and collagen activation.
The primary types of carboxy therapy include aesthetic rejuvenation services, therapeutic medical treatments, rehabilitative and sports medicine applications, and post-surgical recovery programs. Aesthetic rejuvenation services involve procedures designed to enhance skin appearance and overall aesthetics through the controlled delivery of carbon dioxide. These therapies are administered using professional-grade devices or home-use kits. They utilize gases such as carbon dioxide and oxygen. The applications include stretch marks, cellulite, alopecia, psoriasis, and dark circles, while the end users are aesthetic clinics and dermatology centers, hospitals and medical centers, and wellness and spa facilities.
The carboxy therapy market includes revenues earned by entities through personalized treatment protocol design, combination therapy services with aesthetic procedures, maintenance and repeat treatment programs, adverse effect management, patient education and counseling, clinical monitoring of treatment outcomes, and aftercare and recovery support services. The market value includes the value of related goods or consumables used during therapy, such as medical-grade carbon dioxide gas, delivery devices, and associated equipment, when provided as part of the service. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The carboxy therapy market size is expected to see rapid growth in the next few years. It will grow to $20.57 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to increasing demand for personalized cosmetic treatments, rising adoption of regenerative medicine techniques, expansion of wellness and preventive care services, growing focus on evidence-based aesthetic outcomes, increasing investments in advanced therapy devices. Major trends in the forecast period include increasing adoption of personalized aesthetic treatment protocols, rising integration of combination therapy approaches, expansion of non-invasive skin rejuvenation procedures, increasing focus on collagen stimulation therapies, enhanced demand for clinical outcome monitoring.
The growing prevalence of skin aging and cosmetic concerns is anticipated to drive the growth of the carboxy therapy market in the coming years. Skin aging and cosmetic concerns refer to visible signs such as wrinkles, fine lines, skin laxity, dark circles, cellulite, and uneven skin texture experienced by both aging and younger populations globally. The growing prevalence of skin aging and cosmetic concerns is driven by prolonged exposure to ultraviolet radiation, environmental pollution, and lifestyle-related factors that accelerate collagen breakdown and skin degeneration. Carboxy therapy supports the prevalence of skin aging and cosmetic concerns by improving microcirculation, enhancing oxygen delivery, and stimulating collagen regeneration, thereby addressing multiple aesthetic indications through a minimally invasive approach. For example, in June 2024, according to the International Society of Aesthetic Plastic Surgery, a US-based professional organization, facial and head aesthetic procedures experienced significant growth compared to the previous year in 2023, totaling over 6.5 million interventions and reflecting a 19.6% rise. Therefore, the growing prevalence of skin aging and cosmetic concerns is driving the growth of the carboxy therapy market.
Companies operating in the carboxy therapy market are focusing on developing innovative solutions, such as patented sustained carbon dioxide delivery systems for professional‑grade carboxytherapy treatments, to meet the rising demand for safer, more effective non-invasive aesthetic and regenerative skin therapies. Patented sustained carbon dioxide delivery systems are advanced formulations and device technologies that gradually release carbon dioxide over an extended period, enabling deeper skin absorption and enhanced circulation compared with traditional fast-acting gels and packs that dissipate quickly on contact. For example, in August 2025, Lumisque Skincare, a US-based clinical skincare and biomedical company, announced advancements in its CO2Lift carboxytherapy treatment, featuring a patented lactone hydrolysis system that steadily releases carbon dioxide for more than an hour to support deeper tissue absorption and broader therapeutic use. The CO2Lift system is being integrated by physicians and aesthetic practitioners for non-invasive skin regeneration, wound healing support, and enhanced microcirculation, offering a professional‑grade alternative to traditional consumer-grade CO₂ products. Lumisque’s clinical validation and physician adoption underscore the technology’s capability to elevate carboxy therapy beyond basic cosmetic applications, reflecting continued innovation in the market.
In October 2024, PYFAESTHETIC, an Indonesia-based provider of aesthetic dermatology products, medical devices, and professional skincare solutions, collaborated with JM Biotech to bring the latest non-surgical treatment option to Indonesia. With this collaboration, PYFAESTHETIC aimed to expand its dermatology and aesthetic treatment portfolio and accelerate market adoption of non-invasive carboxytherapy through clinical education, product launches, and localized practitioner training. JM Biotech is a South Korea-based provider of CO₂ carboxytherapy products and biotechnology-driven aesthetic solutions.
Major companies operating in the carboxy therapy market are Cynosure Inc., Alma Lasers Ltd., Cosmopro Srl, Cocoon Medical Ltd., MBE Medical Divisions GmbH, Carbossiterapia Italiana Srl, DTA Medical GmbH, Alvi Prague Co., Kastner-Praxisbedarf GmbH, MEDAiON Plasma GmbH, Beijing Jontelaser Technologies Co. Ltd., HyaCorp GmbH, Sublime Skin Ltd., Hyaluronic GmbH, Aesthetic Solutions Ltd., RevitaLaze GmbH, Medcos GmbH, Mezopharma GmbH, Advon Technologies Pvt. Ltd., and Solana Beauty Technology Co. Ltd.
Tariffs are impacting the carboxy therapy market by increasing costs of imported medical-grade carbon dioxide cylinders, delivery devices, precision regulators, and professional treatment equipment. Aesthetic clinics and medical centers in North America and Europe are most affected due to dependence on imported consumables and devices, while Asia-Pacific faces pricing pressure on device exports. These tariffs are raising treatment costs and limiting equipment upgrades. However, they are also encouraging local production of consumables, regional device manufacturing, and innovation in cost-efficient delivery systems that support broader clinical adoption.
The carboxy therapy market research report is one of a series of new reports that provides carboxy therapy market statistics, including carboxy therapy industry global market size, regional shares, competitors with a carboxy therapy market share, detailed carboxy therapy market segments, market trends and opportunities, and any further data you may need to thrive in the carboxy therapy industry. This carboxy therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Carboxy therapy is a minimally invasive medical and cosmetic treatment that involves the controlled injection of medical-grade carbon dioxide beneath the skin or into the dermal layers. The procedure enhances blood flow, promotes collagen formation, and improves tissue oxygen levels. It supports better skin texture, firmness, and localized fat metabolism through improved microcirculation and collagen activation.
The primary types of carboxy therapy include aesthetic rejuvenation services, therapeutic medical treatments, rehabilitative and sports medicine applications, and post-surgical recovery programs. Aesthetic rejuvenation services involve procedures designed to enhance skin appearance and overall aesthetics through the controlled delivery of carbon dioxide. These therapies are administered using professional-grade devices or home-use kits. They utilize gases such as carbon dioxide and oxygen. The applications include stretch marks, cellulite, alopecia, psoriasis, and dark circles, while the end users are aesthetic clinics and dermatology centers, hospitals and medical centers, and wellness and spa facilities.
The carboxy therapy market includes revenues earned by entities through personalized treatment protocol design, combination therapy services with aesthetic procedures, maintenance and repeat treatment programs, adverse effect management, patient education and counseling, clinical monitoring of treatment outcomes, and aftercare and recovery support services. The market value includes the value of related goods or consumables used during therapy, such as medical-grade carbon dioxide gas, delivery devices, and associated equipment, when provided as part of the service. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Carboxy Therapy Market Characteristics
3. Carboxy Therapy Market Supply Chain Analysis
4. Global Carboxy Therapy Market Trends and Strategies
5. Carboxy Therapy Market Analysis Of End Use Industries
7. Global Carboxy Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Carboxy Therapy Total Addressable Market (TAM) Analysis for the Market
9. Carboxy Therapy Market Segmentation
10. Carboxy Therapy Market Regional and Country Analysis
11. Asia-Pacific Carboxy Therapy Market
12. China Carboxy Therapy Market
13. India Carboxy Therapy Market
14. Japan Carboxy Therapy Market
15. Australia Carboxy Therapy Market
16. Indonesia Carboxy Therapy Market
17. South Korea Carboxy Therapy Market
18. Taiwan Carboxy Therapy Market
19. South East Asia Carboxy Therapy Market
20. Western Europe Carboxy Therapy Market
21. UK Carboxy Therapy Market
22. Germany Carboxy Therapy Market
23. France Carboxy Therapy Market
24. Italy Carboxy Therapy Market
25. Spain Carboxy Therapy Market
26. Eastern Europe Carboxy Therapy Market
27. Russia Carboxy Therapy Market
28. North America Carboxy Therapy Market
29. USA Carboxy Therapy Market
30. Canada Carboxy Therapy Market
31. South America Carboxy Therapy Market
32. Brazil Carboxy Therapy Market
33. Middle East Carboxy Therapy Market
34. Africa Carboxy Therapy Market
36. Carboxy Therapy Market Competitive Landscape and Company Profiles
37. Carboxy Therapy Market Other Major and Innovative Companies
41. Carboxy Therapy Market High Potential Countries, Segments and Strategies
42. Appendix
Executive Summary
Carboxy Therapy Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses carboxy therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for carboxy therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The carboxy therapy market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Service Category: Aesthetic Rejuvenation Services; Therapeutic Medical Treatments; Rehabilitative and Sports Medicine; Post Surgical Recovery Programs2) By Product Type: Professional Devices; At-Home Kits
3) By Gas Type: Carbon Dioxide; Oxygen
4) By Application: Stretch Marks; Cellulite; Alopecia; Psoriasis; Dark Circles
5) By End User: Aesthetic Clinics and Dermatology Centers; Hospitals and Medical Centers; Wellness and Spa Centers
Subsegments:
1) By Aesthetic Rejuvenation Services: Facial Skin Tightening Treatments; Body Contouring Treatments; Cellulite Reduction Treatments; Stretch Mark Reduction Treatments; Scar Appearance Improvement Treatments; Skin Texture and Tone Enhancement Treatments2) By Therapeutic Medical Treatments: Chronic Wound Management Treatments; Peripheral Vascular Disorder Treatments; Dermatological Condition Treatments; Pain Management Treatments; Circulatory Disorder Treatments
3) By Rehabilitative and Sports Medicine: Muscle Injury Recovery Treatments; Joint Pain Relief Treatments; Soft Tissue Rehabilitation Treatments; Sports Injury Recovery Treatments; Inflammation Reduction Treatments
4) By Post Surgical Recovery Programs: Postoperative Scar Management Treatments; Edema Reduction Treatments; Tissue Healing Support Treatments; Fibrosis Reduction Treatments; Circulation Improvement Treatments
Companies Mentioned: Cynosure Inc.; Alma Lasers Ltd.; Cosmopro Srl; Cocoon Medical Ltd.; MBE Medical Divisions GmbH; Carbossiterapia Italiana Srl; DTA Medical GmbH; Alvi Prague Co.; Kastner-Praxisbedarf GmbH; MEDAiON Plasma GmbH; Beijing Jontelaser Technologies Co. Ltd.; HyaCorp GmbH; Sublime Skin Ltd.; Hyaluronic GmbH; Aesthetic Solutions Ltd.; RevitaLaze GmbH; Medcos GmbH; Mezopharma GmbH; Advon Technologies Pvt. Ltd.; and Solana Beauty Technology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Carboxy Therapy market report include:- Cynosure Inc.
- Alma Lasers Ltd.
- Cosmopro Srl
- Cocoon Medical Ltd.
- MBE Medical Divisions GmbH
- Carbossiterapia Italiana Srl
- DTA Medical GmbH
- Alvi Prague Co.
- Kastner-Praxisbedarf GmbH
- MEDAiON Plasma GmbH
- Beijing Jontelaser Technologies Co. Ltd.
- HyaCorp GmbH
- Sublime Skin Ltd.
- Hyaluronic GmbH
- Aesthetic Solutions Ltd.
- RevitaLaze GmbH
- Medcos GmbH
- Mezopharma GmbH
- Advon Technologies Pvt. Ltd.
- and Solana Beauty Technology Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | March 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 13.4 Billion |
| Forecasted Market Value ( USD | $ 20.57 Billion |
| Compound Annual Growth Rate | 11.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
